Target- |
MechanismImmunomodulators |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1983 |
100 Clinical Results associated with Wuhan Zhongsheng Yujin Biomedical Co., Ltd.
0 Patents (Medical) associated with Wuhan Zhongsheng Yujin Biomedical Co., Ltd.
100 Deals associated with Wuhan Zhongsheng Yujin Biomedical Co., Ltd.
100 Translational Medicine associated with Wuhan Zhongsheng Yujin Biomedical Co., Ltd.